Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho WG Discusses New "Health Food" System
October 20, 2003
- Nippon Chemiphar to Launch 1st Generic Codeveloped with Ranbaxy in 2005
October 20, 2003
- MEDICAL DEVICE NEWS IN BRIEF
October 20, 2003
- Mochida Returns Toyama Plant to Meiji Yakuhin
October 20, 2003
- Incoming Banyu President Hirate Expresses His Hopes
October 20, 2003
- BUSINESS NEWS IN BRIEF
October 20, 2003
- NEW PRODUCTS
October 20, 2003
- Osaka's ICH-6 to Discuss New GLs for Quality Systems
October 20, 2003
- NHI Prices of Original Products Should Be Cut on Entry of Generics: Dr Sakurai
October 20, 2003
- Insurance Coverage Expected Soon for M-VAC Therapy
October 13, 2003
- 10 Suspected Deaths Due to OTC Drugs Since FY2001: Korosho
October 13, 2003
- Korosho Approves Azwell-Fukujin's Business Rebuilding Plan
October 13, 2003
- BULLETIN
October 13, 2003
- REGULATORY NEWS IN BRIEF
October 13, 2003
- WORLD NEWS IN BRIEF
October 13, 2003
- Medical Members Submit Petition on Medical Fee Revision at Chuikyo
October 13, 2003
- To Ensure Bilateral Communication between Banyu, Merck: Mr Hirate
October 13, 2003
- Full Bungyo to Increase Medical Costs by \1.7 Tril.: Report
October 13, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 13, 2003
- Mr Butler Explains PhRMA Report on Value of New Medicines
October 13, 2003
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…